Broadwater Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Broadwater Capital's BIIB Position: Q3 2026 in Review
Broadwater Capital held its Biogen (BIIB) position steady in Q3 2026 at 100 shares worth $22.6K. The position accounts for 0.02% of the portfolio, ranked #127.
Broadwater Capital first reported a position in BIIB in Q4 2023 and has held it in 12 quarters since. The position peaked at $36.2K in Q4 2023. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Broadwater Capital held 100 shares of Biogen worth $22.6K as of Q3 2026.
- Broadwater Capital left its Biogen share count unchanged in Q3 2026.
- Biogen made up 0.02% of Broadwater Capital's portfolio in Q3 2026, its #127 holding.
- Broadwater Capital first reported a position in Biogen in Q4 2023 and has held it in 12 quarters since.
- Broadwater Capital's Biogen position peaked at $36.2K in Q4 2023.
- 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.